Numminen S - Search Results

1

Oral carmofur in advanced gastrointestinal cancer.

Gröhn P, Heinonen E, Kumpulainen E, Länsimies H, Lantto A, Salmi R, Pyrhönen S, Numminen S. Gröhn P, et al. Among authors: numminen s. Am J Clin Oncol. 1990 Dec;13(6):477-9. doi: 10.1097/00000421-199012000-00005. Am J Clin Oncol. 1990. PMID: 2239802

2

Combination of carmofur and interferon-alpha-2B in advanced gastrointestinal cancer--a phase II pilot study.

Gröhn P, Helle L, Numminen S, Heinonen E. Gröhn P, et al. Among authors: numminen s. Acta Oncol. 1994;33(6):711-3. Acta Oncol. 1994. PMID: 7946457 Clinical Trial. No abstract available.

3

A phase II study of metastatic melanoma treated with a combination of interferon alfa 2b, dacarbazine and nimustine.

Gröhn P, Kumpulainen E, Nuortio L, Hakala T, Vuoristo MS, Korpela M, Heikkinen M, Salmi R, Jakobsson M, Numminen S. Gröhn P, et al. Among authors: numminen s. Eur J Cancer. 1992;28(2-3):441-3. doi: 10.1016/s0959-8049(05)80072-3. Eur J Cancer. 1992. PMID: 1591060 Clinical Trial.

4

Open phase II study of high-dose toremifene as first-line therapy for advanced breast cancer.

Hietanen T, Hakala T, Baltina D, Johansson R, Numminen S, Helle L, Valavaara R, Thölix E. Hietanen T, et al. Among authors: numminen s. Oncology (Williston Park). 1997 May;11(5 Suppl 4):37-40. Oncology (Williston Park). 1997. PMID: 9165505 Clinical Trial.

5

High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer. An ongoing phase II multicenter Finnish-Latvian cooperative study.

Hietanen T, Baltina D, Johansson R, Numminen S, Hakala T, Helle L, Valavaara R. Hietanen T, et al. Among authors: numminen s. Breast Cancer Res Treat. 1990 Aug;16 Suppl:S37-40. doi: 10.1007/BF01807143. Breast Cancer Res Treat. 1990. PMID: 2149284 Clinical Trial.

6

Chemotherapy in advanced breast carcinoma. Comparison between doxorubicin-cyclophosphamide and cyclophosphamide-methotrexate-5-fluorouracil-vincristine-prednisone.

Parvinen LM, Numminen S. Parvinen LM, et al. Among authors: numminen s. Acta Radiol Oncol. 1985 Sep-Oct;24(5):391-4. doi: 10.3109/02841868509134406. Acta Radiol Oncol. 1985. PMID: 3002135 Clinical Trial.

7

Aclarubicin in the treatment of advanced gastrointestinal adenocarcinoma.

Elomaa I, Salmo M, Roos L, Helle L, Korpela M, Numminen S, Virén M, Allonen H. Elomaa I, et al. Among authors: numminen s. Acta Oncol. 1990;29(5):636-7. doi: 10.3109/02841869009090066. Acta Oncol. 1990. PMID: 2206579 No abstract available.

8

Factors Influencing Quality of Life Six Months after a First-Ever Ischemic Stroke: Focus on Thrombolyzed Patients.

Numminen S, Korpijaakko-Huuhka AM, Parkkila AK, Kulkas T, Numminen H, Dastidar P, Jehkonen M. Numminen S, et al. Folia Phoniatr Logop. 2016;68(2):86-91. doi: 10.1159/000449218. Epub 2016 Sep 30. Folia Phoniatr Logop. 2016. PMID: 27684629

9

Frugal energy innovations for developing countries - a framework.

Numminen S, Lund PD. Numminen S, et al. Glob Chall. 2016 Sep 30;1(1):9-19. doi: 10.1002/gch2.1012. eCollection 2017 Jan. Glob Chall. 2016. PMID: 31565251 Free PMC article.

10

Inoperable and recurrent carcinoma of the rectum and rectosigmoid. Aspects of radiation treatment and prognosis.

Nordman E, Grönroos M, Aho AJ, Numminen S. Nordman E, et al. Among authors: numminen s. Ann Chir Gynaecol. 1977;66(6):265-8. Ann Chir Gynaecol. 1977. PMID: 603215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters